Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...
HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...
HOUSTON — The fight against HIV has come a long way, and new advancements in prevention are changing the game. One of the latest breakthroughs is a long-lasting injectable form of PrEP (pre-exposure ...
Apretude is a medicine approved by the FDA in 2021 to reduce the risk of contracting HIV through sexual contact, also known as pre-exposure prophylaxis (PrEP). PrEP is used to prevent the transmission ...
Add Yahoo as a preferred source to see more of our stories on Google. a group of fit men in blue and white outfits promote national prep day Today is the first National PrEP Day — a new annual event ...
Kind Clinic of Austin Koenig is holding its same-day HIV prevention medication pilot program starting March 13 until April 17.
India introduced PrEP guidelines in 2022, but access remains limited due to lack of public rollout, low awareness, and high costs. Meanwhile, HIV prevalence has declined overall but remains ...
Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes Zandraetta Tims-Cook, MD, MPH, AAHIVS In the US, we have made remarkable ...
A U.S. study by San Diego State University and the RAND Corporation found that intimate partner violence among sexual minority men does not directly reduce PrEP use but can increase stigma and lower ...
Nigeria has taken delivery of long-acting injectable lenacapavir (LEN) for HIV prevention, a development the Federal Ministry of ...
The Federal Government says Nigeria has received Long-Acting Injectable Lenacapavir for HIV prevention, marking a new step in the country’s ...
Nigeria receives long-acting injectable Lenacapavir for HIV prevention, expanding PrEP options and improving adherence for populations at risk.